Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression-Reference-Cited by-同舟云学术

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

Published:2016-03-18 Issue:16 Volume:7 Page:21840-21852
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lasorsa Vito Alessandro¹²,Formicola Daniela¹²,Pignataro Piero¹²,Cimmino Flora¹²,Calabrese Francesco Maria³,Mora Jaume⁴,Esposito Maria Rosaria⁵,Pantile Marcella⁵,Zanon Carlo⁵,De Mariano Marilena⁶,Longo Luca⁶,Hogarty Michael D.⁷,de Torres Carmen⁴,Tonini Gian Paolo⁵,Iolascon Achille¹²,Capasso Mario¹²⁸

Affiliation:

1. University of Naples Federico II, Department of Molecular Medicine and Medical Biotechnology, Naples, Italy

2. CEINGE Biotecnolgie Avanzate, Naples, Italy

3. University of Bari, Department of Biology, Bari, Italy

4. Hospital Sant Joan de Déu, Developmental Tumor Biology Laboratory and Department of Oncology, Esplugues de Llobregat, Barcelona, Spain

5. Pediatric Research Institute (IRP), Fondazione Città della Speranza, Neuroblastoma Laboratory, Padua, Italy

6. U.O.C. Bioterapie, IRCCS AOU San Martino-IST, National Cancer Research Institute, Genoa, Italy

7. Children's Hospital of Philadelphia, Division of Oncology, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America

8. IRCCS SDN, Istituto di Ricerca Diagnostica e Nucleare, Naples, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer;2024-08-19

2. Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine;2023-10

3. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma;JNCI: Journal of the National Cancer Institute;2023-09-09

4. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival;JNCI: Journal of the National Cancer Institute;2023-09-09

5. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma;Gene;2023-04